Document Type

Dissertation

Date of Award

8-31-2018

Degree Name

Doctor of Philosophy in Biomedical Engineering - (Ph.D.)

Department

Biomedical Engineering

First Advisor

Treena Livingston Arinzeh

Second Advisor

George Collins

Third Advisor

Bryan J. Pfister

Fourth Advisor

Pranela Rameshwar

Fifth Advisor

J. Christopher Fritton

Abstract

Articular cartilage has limited healing and self-repair capability due to the absence of vasculature, lymphatic vessels, and nerves. Damage to articular cartilage becomes irreversible leading to formation of osteoarthritis that could severely degrade a person's quality of life. Approximately, 5-10% of cartilage tissue is made up of glycosaminoglycans (GAG), which sequester growth factors as well as provide structural integrity to the native cartilage tissue. Transforming growth factor-beta3 (TGF-β3) is an important growth factor for inducing chondrogenesis in mesenchymal stem cells (MSCs). Bioavailability of TGF-β3 plays a critical role in cartilage repair both in vitro and in vivo. This study evaluates the chondrogenic differentiation of MSCs on scaffolds that contain cellulose sulfate, a GAG mimetic derived from cellulose, in vitro. Since the level of sulfation in GAGs can play a role in growth factor binding, two degrees of sulfation are evaluated, partially sulfated cellulose (pSC) and fully sulfated cellulose (NaCS). Comparisons are made with scaffolds containing native GAGs. Scaffolds are prepared by electrospinning gelatin with cellulose sulfate or the native GAGs and are crosslinked using EDC-NHS chemistry. All scaffolds consist of fibers having average diameters of approximately 3 gm and inter-fiber spacing of approximately 30 gm. TGF-β3 is loaded onto all scaffolds with no statistical differences in the amount of TGF-β3 detected between groups. In in vitro studies, all scaffolds support cell growth. By day 28, cells on scaffolds loaded with TGF-β3 show enhanced expression of cartilage markers, sulfated GAGs, and collagen type II, in comparison to media supplemented TGF-β3. Cells on scaffolds with NaCS and native GAGs loaded with TGF-β3 express similar amounts of GAG and collagen type II. However, lower amounts of collagen type I are expressed by cells on both pSC and NaCS scaffolds as compared to scaffolds containing native GAGs, demonstrating a more homogeneous cartilage matrix produced on the pSC and NaCS containing scaffolds. Gene expression for collagen type II, aggrecan, sox9 and chondroadherin also is expressed at high levels for cells on NaCS containing scaffolds loaded with TGF-β3 by day 14. Lower expression of the hypertrophic markers, collagen type X and VEGF, is seen for cells on all scaffolds loaded with TGF-β3 with the least expression on NaCS containing scaffolds by day 28 in comparison to scaffolds in media supplemented TGF-β3 controls. NaCS containing scaffolds also has the greatest binding affinity for TGF-β3 in comparison to all other scaffolds. MSC chondrogenic differentiation also is examined on pSC and NaCS containing scaffolds in a dynamic compression bioreactor to mimic physiological loading conditions. Findings demonstrates a more homogeneous cartilage-like matrix produced for cells on NaCS containing scaffolds. Therefore, these studies demonstrate that loading TGF-β3 on the scaffolds containing cellulose sulfate enhances MSC chondrogenic differentiation and may be a viable approach for enhancing cartilage tissue regeneration.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.